ABSTRACT
Abstract Innovation is the driving force that is able to create and transform products, processes, and organization in the health system. Innovation in the field of pharmaceutical assistance covers a wide spectrum of aspects, from drug discovery to pharmaceutical care, contributing to the improvement in treatments through novel drugs or methods. This work will present the major characteristics of innovation with special emphasis on aspects pertaining to pharmaceutical assistance. The types and models of innovation, as well as the interaction between academia and industry, will be presented with examples of successful products and methods. In addition, the challenges and perspectives for innovation in pharmaceutical assistance will be discussed with a focus on drug discovery.
Subject(s)
Pharmaceutical Services/classification , Creativity , Health Systems , Pharmaceutical Preparations/classification , Reference Drugs , Drug Discovery/trends , Industry/trends , MethodsABSTRACT
3D-printing (3DP) is the art and science of printing in a new dimension using 3D printers to transform 3D computer aided designs (CAD) into life-changing products. This includes the design of more effective and patient-friendly pharmaceutical products as well as bio-inspired medical devices. It is poised as the next technology revolution for the pharmaceutical and medical-device industries. After decorous implementation scientists in collaboration with CAD designers have produced innovative medical devices ranging from pharmaceutical tablets to surgical transplants of the human face and skull, spinal implants, prosthetics, human organs and other biomaterials. While 3DP may be cost-efficient, a limitation exists in the availability of 3D printable biomaterials for most applications. In addition, the loss of skilled labor in producing medical devices such as prosthetics and other devices may affect developing economies. This review objectively explores the potential growth and impact of 3DP costs in the medical industry.
Subject(s)
Computer-Aided Design/economics , Industry/trends , Printing, Three-Dimensional/economics , Computer-Aided Design/trends , Drug Industry/economics , Drug Industry/trends , Equipment Design , Equipment and Supplies/economics , Humans , Industry/economics , Pharmaceutical Preparations/economics , Printing, Three-Dimensional/trendsSubject(s)
Biotechnology/trends , Industry/trends , Proteomics/trends , Genome , Pharmaceutical Preparations , ProteomeABSTRACT
During the past few years, hospitals have been actively evaluating the use of newer-type stocking systems for their pharmacies. While "stockless," a just-in-time (JIT) variation, appears to be emerging as perhaps the most promising method, it is far from being accepted as the industry standard. Because of growing concern for health care reform, with its cost containment component, it may well be anticipated that both the pace and profoundness of these efforts will continue to intensify.
